FDA's determination of the safety and effectiveness of a diagnostic radiopharmaceutical includes consideration of the following:
21 C.F.R. § 315.3
FDA's determination of the safety and effectiveness of a diagnostic radiopharmaceutical includes consideration of the following:
21 C.F.R. § 315.3